Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capping actin protein of muscle Z-line subunit beta (CAPZB) is the β subunit of the heterodimeric F-actin capping protein, a key regulator of actin filament dynamics found in nearly all eukaryotic cells[1][4]. CAPZB binds to the barbed (rapidly growing) ends of actin filaments, blocking both their assembly and disassembly, thus stabilizing filament length and organizing the cytoskeleton in muscle and nonmuscle cells[1][3]. In muscle, CAPZB is anchored at the Z-disk, where it maintains sarcomere structure essential for muscle contraction and prevents mechanical stress-induced damage[2][3][5]. Beyond muscles, CAPZB is also required for processes like cell morphology maintenance, differentiation, neural crest migration, and auditory function by governing the architecture of branched actin networks and stereocilia[2][4][5]. Disruption or dysregulation of CAPZB is associated with developmental disorders such as craniofacial anomalies and muscle malformation, but it is not a current direct therapeutic target[1][2][3][7].
Not applicable; no drugs are known to target CAPZB directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capping actin protein of muscle Z-line subunit beta (CAPZB).